Please Wait.....
Report
Europe Ophthalmology Drug And Device - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)
Market Report I 2025-07-01 I 85 Pages I Mordor Intelligence
Europe Ophthalmology Drug And Device Market Analysis
The Europe ophthalmic devices and drugs market reached USD 12.6 billion in 2025 and is expected to climb to USD 18.8 billion by 2030, advancing at a 7.9% CAGR. Demographic aging, rising incidence of chronic eye conditions, and steady migration toward minimally invasive surgery sustain this expansion. Hospitals continue to dominate procedure volumes, yet outpatient facilities are capturing the incremental growth as payers encourage cost-efficient care models. AI-enabled diagnostic platforms are improving screening throughput in Germany and the UK, while regulatory actions such as the EMA's 2024 Durysta withdrawal are redirecting R&D toward safer sustained-release implants. Consolidation among leading manufacturers and new vertical integration moves by EssilorLuxottica underscore the sector's shift toward end-to-end eye-care ecosystems.
Europe Ophthalmology Drug And Device Market Trends and Insights
Growing Prevalence of Chronic Eye Diseases
The incidence of age-related macular degeneration and diabetic retinopathy is climbing as Europe's population ages, generating a durable demand base for both surgical and pharmaceutical interventions. Health systems are embedding ophthalmic screening into routine primary care, and German pilots using AI achieved 100% sensitivity for diabetic-retinopathy detection, catalyzing wider adoption. The economic burden of retinal disorders is estimated to hit EUR 99.8 billion by 2030, bolstering procurement budgets for advanced diagnostic equipment and sustained-release injectables.
Expanding Geriatric Population Base
Individuals aged 65 years or older constitute Europe's fastest-growing cohort and exhibit the highest prevalence of cataract, glaucoma, and AMD. National services are tackling surgical backlogs by contracting private providers, a model that raised UK cataract procedure volumes 40% over pre-pandemic levels. A larger elderly population simultaneously fuels premium IOL demand, reflecting patient preference for spectacle independence and rapid visual recovery.
High Cost and Reimbursement Gaps for Premium Lenses/MIGS
Cataract surgery tariff disparities range from EUR 432.5 (USD 507.1) in Poland to EUR 3,411.96 (USD 4,001.21) in Portugal, causing uneven patient access to premium IOLs. Co-payment requirements depress uptake in social-insurance markets, while MIGS reimbursement remains procedure-specific, creating friction for innovators and clinicians alike. Germany's 2025 abolition of fixed prices for visual aids illustrates the fluid reimbursement landscape.
Other drivers and restraints analyzed in the detailed report include:
Rapid Adoption of Minimally Invasive Glaucoma Surgery / AI-Enabled Diagnostic Imaging & Remote Screening Rollout / Stringent EU MDR Compliance Burden on SMEs /
For complete list of drivers and restraints, kindly check the Table Of Contents.
Segment Analysis
Surgical devices generated 46.7% of total 2024 revenue within the Europe ophthalmic devices and drugs market and continue to command premium pricing due to constant innovation. Alcon holds about 60% global share in presbyopia-correcting IOLs and has replicated similar penetration across major EU economies. Phaco platforms and femtosecond lasers secure attractive service contracts, while the fastest-expanding sub-segment is MIGS. The segment's value proposition rises as bundled cataract-plus-MIGS procedures reduce overall care episodes.
Meanwhile, new hydrogel implants and refillable ocular reservoirs target adherence gaps. Vision-care devices retain stable revenue streams via contact-lens material upgrades and blue-light-filter spectacles. Alcon's 2025 Clareon PanOptix Pro IOL, boasting 94% light utilization, exemplifies engineering efforts that sustain price premiums. Across all modalities, companies intensify R&D to capture an ageing demographic seeking spectacle independence and rapid recovery.
The Europe Ophthalmic Devices and Drugs Market Report is Segmented by Product (Devices, Drugs), Disease (Glaucoma, Cataract, Age-Related Macular Degeneration, Diabetic Retinopathy, and More), End User (Hospitals, Specialty Clinics & ASCs, Retail Pharmacies & Optical Stores, Online Pharmacies), and Geography (Germany, United Kingdom, France, Italy, Spain, Rest of Europe). The Market Forecasts are Provided in Terms of Value (USD).
List of Companies Covered in this Report:
Alcon / Carl Zeiss / Johnson&Johnson / Bausch + Lomb Corp. / EssilorLuxottica / Novartis AG (incl. Sandoz & Sandoz Vision Care) / Roche / Pfizer / Glaukos Corp. / Santen Pharmaceuticals / Staar Surgical Co. / Topcon Corp. / Nidek / HAAG-Streit / Ziemer Group / Canon / Hoya Corp. / Pentax Medical / CooperVision Inc. / Danaher / Abbvie /
Additional Benefits:
The market estimate (ME) sheet in Excel format /
3 months of analyst support /
1 Introduction
1.1 Study Assumptions & Market Definition
1.2 Scope of the Study
2 Research Methodology
3 Executive Summary
4 Market Landscape
4.1 Market Overview
4.2 Market Drivers
4.2.1 Growing Prevalence Of Chronic Eye Diseases
4.2.2 Expanding Geriatric Population Base
4.2.3 Rapid Adoption Of Minimally-Invasive Glaucoma Surgery (MIGS)
4.2.4 AI-Enabled Diagnostic Imaging & Remote Screening Rollout
4.2.5 Surge In Sustained-Release Ocular Drug-Delivery Approvals
4.2.6 EU Funding Programs For Ophthalmic R&D And Start-Ups
4.3 Market Restraints
4.3.1 High Cost & Reimbursement Gaps For Premium Lenses/MIGS
4.3.2 Stringent EU MDR Compliance Burden On SMEs
4.3.3 Sub-Optimal Patient Adherence To Multi-Dose Eyedrop Regimens
4.3.4 Supply-Chain-Driven API Shortages For Sterile Ophthalmic Drugs
4.4 Supply Chain Analysis
4.5 Regulatory Landscape
4.6 Technological Outlook
4.7 Porter's Five Forces Analysis
4.7.1 Threat of New Entrants
4.7.2 Bargaining Power of Buyers
4.7.3 Bargaining Power of Suppliers
4.7.4 Threat of Substitute Products
4.7.5 Intensity of Competitive Rivalry
5 Market Size & Growth Forecasts (Value)
5.1 By Product
5.1.1 Devices
5.1.1.1 Surgical Devices
5.1.1.1.1 Intra-ocular Lenses
5.1.1.1.2 Ophthalmic Lasers
5.1.1.1.3 Phacoemulsification Systems
5.1.1.1.4 Other Surgical Devices
5.1.1.2 Diagnostic Devices
5.1.1.2.1 Optical Coherence Tomography Scanners
5.1.1.2.2 Fundus Cameras
5.1.1.2.3 Tonometers
5.1.1.2.4 Other Diagnostic Devices
5.1.1.3 Vision Care Devices
5.1.1.3.1 Contact Lenses
5.1.1.3.2 Spectacle Lenses
5.1.2 Drugs
5.1.2.1 Glaucoma Drugs
5.1.2.2 Retinal Disorder Drugs
5.1.2.3 Dry-Eye Therapies
5.1.2.4 Anti-Allergy / Anti-Inflammatory Drugs
5.1.2.5 Anti-Infective Drugs
5.1.2.6 Other Drugs
5.2 By Disease
5.2.1 Glaucoma
5.2.2 Cataract
5.2.3 Age-related Macular Degeneration
5.2.4 Diabetic Retinopathy
5.2.5 Inflammatory Diseases
5.2.6 Refractive Disorders
5.2.7 Other Diseases
5.3 By End User
5.3.1 Hospitals
5.3.2 Specialty Clinics & ASCs
5.3.3 Retail Pharmacies & Optical Stores
5.3.4 Online Pharmacies
5.4 Geography
5.4.1 Germany
5.4.2 United Kingdom
5.4.3 France
5.4.4 Italy
5.4.5 Spain
5.4.6 Rest of Europe
6 Competitive Landscape
6.1 Market Concentration
6.2 Market Share Analysis
6.3 Company Profiles {(includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share for key companies, Products & Services, and Recent Developments)}
6.3.1 Alcon AG
6.3.2 Carl Zeiss Meditec AG
6.3.3 Johnson & Johnson Vision
6.3.4 Bausch + Lomb Corp.
6.3.5 EssilorLuxottica SA
6.3.6 Novartis AG (incl. Sandoz & Sandoz Vision Care)
6.3.7 Roche Holding AG
6.3.8 Pfizer Inc.
6.3.9 Glaukos Corp.
6.3.10 Santen Pharmaceutical Co. Ltd
6.3.11 Staar Surgical Co.
6.3.12 Topcon Corp.
6.3.13 Nidek Co. Ltd
6.3.14 Haag-Streit Group
6.3.15 Ziemer Group AG
6.3.16 Canon Medical Systems Corp.
6.3.17 Hoya Corp. / Pentax Medical
6.3.18 CooperVision Inc.
6.3.19 Leica Microsystems GmbH
6.3.20 Allergan (AbbVie)
7 Market Opportunities & Future Outlook
7.1 White-space & Unmet-need Assessment
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security